Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/
Highlights this week included:
Intergovernmental Meeting on Pandemic Influenza Preparedness, Geneva: tension over IP issues related to virus and vaccine sharing (Intellectual Property Watch) (Intellectual Property Watch)
Actos (Pioglitazone) – US: CAFC affirms attorney fee of over $16 million in connection with ANDA patent challenge: Takeda v Mylan (Hal Wegner) (Law360) (Orange Book Blog) (Promote the Progress)
Valcyte (Valganciclovir) – India: Madras High Court sets aside Roche’s Valcyte patent and orders Patent Office to hear pre-grant oppositions against Roche’s application; Roche challenges decision (Spicy IP) (Managing Intellectual Property) (Patent Circle)
General
Alternative proposal for enhancing developing country access to patented medicines presented at 4th annual conference on technology commercialisation, Amman, Jordan (Intellectual Property Watch)
Intergovernmental Meeting on Pandemic Influenza Preparedness, Geneva: tension over IP issues related to virus and vaccine sharing (Intellectual Property Watch) (Intellectual Property Watch)
11th annual conference of the International Generic Pharmaceutical Alliance: Lamy challenges discontented WTO members to use TRIPS public health review; Gurry defends ‘respect’ for IP (Intellectual Property Watch) (Intellectual Property Watch)
Africa: Rapid rise in African anti-counterfeiting efforts led by developed nations (Intellectual Property Watch) (response from Afro-IP)
EU: Advanced Therapy Medicinal Products Regulation (EC) No 1394/2007 applies from 30 December 2008 (Catch Us If You Can!!!)
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas)
EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs)
US: Patent Office assault on pharma industry (PLI)
US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs)
US: Merck & Co starts generic arm BioVentures to copy biologic medicine (GenericsWeb)
Products
Actos (Pioglitazone) – US: CAFC affirms attorney fee of over $16 million in connection with ANDA patent challenge: Takeda v Mylan (Hal Wegner) (Law360) (Orange Book Blog) (Promote the Progress)
Clarinex (Desloratadine) – US: Perrigo, Sepracor settle Clarinex patent suit (Law360)
Cymbalta (Duloxetine) – US: Eli Lilly fires off another Cymbalta patent suit, this time against Sun Pharmaceuticals (Law360)
Detrol (Tolterodine) – US: Teva, Pfizer both score wins in Detrol patent fight (Law360)
Doryx (Doxycycline) – US: Warner Chilcott announces receipt of Paragraph IV Certification Notice that Mutual Pharmaceutical Co and Mylan have filed ANDAs for generic Doryx (GenericsWeb)
Femara (Letrozole) – US: Mylan and Novartis settle Femara litigation (Patent Docs)
Fortical (Calcitonin-salmon) – US: Apotex preliminarily enjoined from marketing generic equivalent in patent infringement lawsuit brought by Unigene (GenericsWeb)
Ritalin (Methylphenidate) – US: KV Pharmaceutical Co accuses Novartis and Celgene of Sherman Act violations in new counterclaims to their patent infringement suit over Ritalin (Law360)
Seroquel (Quetiapine) – US: AstraZeneca sues Handa Pharmaceuticals for the third time since July over its bid to produce generic Seroquel (Law360)
Skelaxin (Metaxalone) – US: King Pharmaceuticals sues Sandoz to halt generic Skelaxin (Law360)
Stalevo (Carbidopa, Levodopa, Entacapone) – US: Orion files patent infringement lawsuit to block Wockhardt from marketing generic Stalevo (Law360) (GenericsWeb)
Testim (Testosterone) – US: Auxilium sues Upsher-Smith over Testim ANDA (Law360)
Valcyte (Valganciclovir) – India: Madras High Court sets aside Roche’s Valcyte patent and orders Patent Office to hear pre-grant oppositions against Roche’s application; Roche challenges decision (Spicy IP) (Managing Intellectual Property) (Patent Circle)
Valcyte (Valganciclovir) – India: Bombay High Court temporarily enjoins Cipla from using VALCEPT for Valganciclovir (Spicy IP)
Viagra (Sildenafil) – Austria: Pfizer takes legal action over STYRIAGRA for natural erectile dysfunction remedy (Class 46)